Skip to main content
Top
Published in: Arthritis Research & Therapy 4/2013

Open Access 01-08-2013 | Research article

Hypercholesterolemia boosts joint destruction in chronic arthritis. An experimental model aggravated by foam macrophage infiltration

Authors: I Prieto-Potín, JA Roman-Blas, MJ Martínez-Calatrava, R Gómez, R Largo, Gabriel Herrero-Beaumont

Published in: Arthritis Research & Therapy | Issue 4/2013

Login to get access

Abstract

Objective

The aim of this study was to determine whether hypercholesterolemia increases articular damage in a rabbit model of chronic arthritis.

Methods

Hypercholesterolemia was induced in 18 rabbits by administrating a high-fat diet (HFD). Fifteen rabbits were fed normal chow as controls. Chronic antigen-induced arthritis (AIA) was induced in half of the HFD and control rabbits, previously immunized, by intra-articular injections of ovalbumin. After sacrifice, lipid and systemic inflammation markers were analyzed in blood serum. Synovium was analyzed by Krenn score, multinucleated cell counting, immunohistochemistry of RAM11 and CD31, and TNF-α and macrophage chemoattractant protein-1 (MCP-1) gene expression. Active bone resorption was assessed by protein expression of receptor activator of nuclear factor kappa-B ligand (RANKL), osteoprotegerin (OPG) and quantification of cathepsin K, contact surface and the invasive area of pannus into bone.

Results

Rabbits receiving the HFD showed higher total serum cholesterol, HDL, triglycerides and CRP levels than rabbits fed a normal diet. Synovitis score was increased in HFD, and particularly in AIA and AIA + HFD groups. AIA + HFD synovium was characterized by a massive infiltration of RAM11+ cells, higher presence of multinucleated foam cells and bigger vascularization than AIA. Cathepsin K+ osteoclasts and the contact surface of bone resorbing pannus were also increased in rabbits with AIA + HFD compared with AIA alone. Synovial TNF-α and MCP-1 gene expression was increased in AIA and HFD rabbits compared with healthy animals. RANKL protein expression in AIA and AIA + HFD groups was higher compared with either HFD or normal groups.

Conclusions

This experimental model demonstrates that hypercholesterolemia increments joint tissue damage in chronic arthritis, with foam macrophages being key players in this process.
Appendix
Available only for authorised users
Literature
1.
go back to reference Gremese E, Ferraccioli G: The metabolic syndrome: the crossroads between rheumatoid arthritis and cardiovascular risk. Autoimmun Rev. 2011, 10: 582-589. 10.1016/j.autrev.2011.04.018.CrossRefPubMed Gremese E, Ferraccioli G: The metabolic syndrome: the crossroads between rheumatoid arthritis and cardiovascular risk. Autoimmun Rev. 2011, 10: 582-589. 10.1016/j.autrev.2011.04.018.CrossRefPubMed
2.
go back to reference Gabriel S: The epidemiology of rheumatoid arthritis. Rheum Dis Clin North Am. 2001, 27: 269-281. 10.1016/S0889-857X(05)70201-5.CrossRefPubMed Gabriel S: The epidemiology of rheumatoid arthritis. Rheum Dis Clin North Am. 2001, 27: 269-281. 10.1016/S0889-857X(05)70201-5.CrossRefPubMed
3.
go back to reference Romero FI, Martínez-Calatrava MJ, Sánchez-Pernaute O, Gualillo O, Largo R, Herrero-Beaumont G: Pharmacological modulation by celecoxib of cachexia associated with experimental arthritis and atherosclerosis in rabbits. Br J Pharmacol. 2010, 161: 1012-1022. 10.1111/j.1476-5381.2010.00957.x.PubMedCentralCrossRefPubMed Romero FI, Martínez-Calatrava MJ, Sánchez-Pernaute O, Gualillo O, Largo R, Herrero-Beaumont G: Pharmacological modulation by celecoxib of cachexia associated with experimental arthritis and atherosclerosis in rabbits. Br J Pharmacol. 2010, 161: 1012-1022. 10.1111/j.1476-5381.2010.00957.x.PubMedCentralCrossRefPubMed
4.
go back to reference Scotece M, Conde J, Gómez R, López V, Pino J, González A, Lago F, Gómez-Reino JJ, Gualillo O: Role of adipokines in atherosclerosis: interferences with cardiovascular complications in rheumatic diseases. Mediators Inflamm. 2012, 2012: 125458-PubMedCentralCrossRefPubMed Scotece M, Conde J, Gómez R, López V, Pino J, González A, Lago F, Gómez-Reino JJ, Gualillo O: Role of adipokines in atherosclerosis: interferences with cardiovascular complications in rheumatic diseases. Mediators Inflamm. 2012, 2012: 125458-PubMedCentralCrossRefPubMed
5.
go back to reference Lago R, Gómez R, Lago F, Gómez-Reino J, Gualillo O: Leptin beyond body weight regulation--current concepts concerning its role in immune function and inflammation. Cell Immunol. 2008, 252: 139-145. 10.1016/j.cellimm.2007.09.004.CrossRefPubMed Lago R, Gómez R, Lago F, Gómez-Reino J, Gualillo O: Leptin beyond body weight regulation--current concepts concerning its role in immune function and inflammation. Cell Immunol. 2008, 252: 139-145. 10.1016/j.cellimm.2007.09.004.CrossRefPubMed
6.
go back to reference Gómez R, Conde J, Scotece M, Gómez-Reino JJ, Lago F, Gualillo O: What's new in our understanding of the role of adipokines in rheumatic diseases?. Nat Rev Rheumatol. 2011, 7: 528-536. 10.1038/nrrheum.2011.107.CrossRefPubMed Gómez R, Conde J, Scotece M, Gómez-Reino JJ, Lago F, Gualillo O: What's new in our understanding of the role of adipokines in rheumatic diseases?. Nat Rev Rheumatol. 2011, 7: 528-536. 10.1038/nrrheum.2011.107.CrossRefPubMed
7.
go back to reference Li J, Hsu H-C, Mountz JD: Managing macrophages in rheumatoid arthritis by reform or removal. Curr Rheumatol Rep. 2012, 14: 445-454. 10.1007/s11926-012-0272-4.PubMedCentralCrossRefPubMed Li J, Hsu H-C, Mountz JD: Managing macrophages in rheumatoid arthritis by reform or removal. Curr Rheumatol Rep. 2012, 14: 445-454. 10.1007/s11926-012-0272-4.PubMedCentralCrossRefPubMed
8.
go back to reference Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H: Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003, 112: 1821-1830.PubMedCentralCrossRefPubMed Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H: Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003, 112: 1821-1830.PubMedCentralCrossRefPubMed
9.
go back to reference Libby P, Ridker PM, Hansson GK: Progress and challenges in translating the biology of atherosclerosis. Nature. 2011, 473: 317-325. 10.1038/nature10146.CrossRefPubMed Libby P, Ridker PM, Hansson GK: Progress and challenges in translating the biology of atherosclerosis. Nature. 2011, 473: 317-325. 10.1038/nature10146.CrossRefPubMed
11.
go back to reference Jodon de Villeroché V, Avouac J, Ponceau A, Ruiz B, Kahan A, Boileau C, Uzan G, Allanore Y: Enhanced late-outgrowth circulating endothelial progenitor cell levels in rheumatoid arthritis and correlation with disease activity. Arthritis Res Ther. 2010, 12: R27-10.1186/ar2934.PubMedCentralCrossRefPubMed Jodon de Villeroché V, Avouac J, Ponceau A, Ruiz B, Kahan A, Boileau C, Uzan G, Allanore Y: Enhanced late-outgrowth circulating endothelial progenitor cell levels in rheumatoid arthritis and correlation with disease activity. Arthritis Res Ther. 2010, 12: R27-10.1186/ar2934.PubMedCentralCrossRefPubMed
12.
go back to reference Paleolog E: It's all in the blood: circulating endothelial progenitor cells link synovial vascularity with cardiovascular mortality in rheumatoid arthritis?. Arthritis Res Ther. 2005, 7: 270-272. 10.1186/ar1850.PubMedCentralCrossRefPubMed Paleolog E: It's all in the blood: circulating endothelial progenitor cells link synovial vascularity with cardiovascular mortality in rheumatoid arthritis?. Arthritis Res Ther. 2005, 7: 270-272. 10.1186/ar1850.PubMedCentralCrossRefPubMed
13.
go back to reference Shantsila E, Watson T, Tse HF Lip GY: New insights on endothelial progenitor cell subpopulations and their angiogenic properties. J Am Coll Cardiol. 2008, 12: 669-671.CrossRef Shantsila E, Watson T, Tse HF Lip GY: New insights on endothelial progenitor cell subpopulations and their angiogenic properties. J Am Coll Cardiol. 2008, 12: 669-671.CrossRef
14.
go back to reference Weber C, Noels H: Atherosclerosis: current pathogenesis and therapeutic options. Nat Med. 2011, 17: 1410-1422. 10.1038/nm.2538.CrossRefPubMed Weber C, Noels H: Atherosclerosis: current pathogenesis and therapeutic options. Nat Med. 2011, 17: 1410-1422. 10.1038/nm.2538.CrossRefPubMed
15.
go back to reference Crowther M: Pathogenesis of atherosclerosis. Hematology Am Soc Hematol Educ Program. 2005, 436-441. Crowther M: Pathogenesis of atherosclerosis. Hematology Am Soc Hematol Educ Program. 2005, 436-441.
16.
go back to reference Largo R, Sánchez-Pernaute O, Marcos ME, Moreno-Rubio J, Aparicio C, Granado R, Ortega L, Egido J, Herrero-Beaumont G: Chronic arthritis aggravates vascular lesions in rabbits with atherosclerosis: a novel model of atherosclerosis associated with chronic inflammation. Arthritis Rheum. 2008, 58: 2723-2734. 10.1002/art.23765.CrossRefPubMed Largo R, Sánchez-Pernaute O, Marcos ME, Moreno-Rubio J, Aparicio C, Granado R, Ortega L, Egido J, Herrero-Beaumont G: Chronic arthritis aggravates vascular lesions in rabbits with atherosclerosis: a novel model of atherosclerosis associated with chronic inflammation. Arthritis Rheum. 2008, 58: 2723-2734. 10.1002/art.23765.CrossRefPubMed
17.
go back to reference EM and Monach P: The rheumatoid joint: synovitis and tissue destruction. Rheumatology. 2011, Philadelphia, PA: Mosby-Elsevier, 911-934. 5 EM and Monach P: The rheumatoid joint: synovitis and tissue destruction. Rheumatology. 2011, Philadelphia, PA: Mosby-Elsevier, 911-934. 5
18.
go back to reference Tak PP, Smeets TOMJM, Daha MR, Kluin PM, Meijers KAE, Brand R, Meinders AED, Breedveld FC: Analysis of the synovial cell infiltrate in relation to local disease activity. Arthritis Rheum. 1997, 40: 217-225. 10.1002/art.1780400206.CrossRefPubMed Tak PP, Smeets TOMJM, Daha MR, Kluin PM, Meijers KAE, Brand R, Meinders AED, Breedveld FC: Analysis of the synovial cell infiltrate in relation to local disease activity. Arthritis Rheum. 1997, 40: 217-225. 10.1002/art.1780400206.CrossRefPubMed
19.
go back to reference De Rycke L, Baeten D, Foell D, Kruithof E, Veys EM, Roth J, De Keyser F: Differential expression and response to anti-TNFalpha treatment of infiltrating versus resident tissue macrophage subsets in autoimmune arthritis. J Pathol. 2005, 206: 17-27. 10.1002/path.1758.CrossRefPubMed De Rycke L, Baeten D, Foell D, Kruithof E, Veys EM, Roth J, De Keyser F: Differential expression and response to anti-TNFalpha treatment of infiltrating versus resident tissue macrophage subsets in autoimmune arthritis. J Pathol. 2005, 206: 17-27. 10.1002/path.1758.CrossRefPubMed
20.
go back to reference Tak PP, Bresnihan B: The pathogenesis and prevention of joint damage in advances from synovial biopsy and tissue analysis. Arthritis Rheum. 2000, 43: 2619-2633. 10.1002/1529-0131(200012)43:12<2619::AID-ANR1>3.0.CO;2-V.CrossRefPubMed Tak PP, Bresnihan B: The pathogenesis and prevention of joint damage in advances from synovial biopsy and tissue analysis. Arthritis Rheum. 2000, 43: 2619-2633. 10.1002/1529-0131(200012)43:12<2619::AID-ANR1>3.0.CO;2-V.CrossRefPubMed
21.
go back to reference Bonet ML, Granados N, Palou A: Molecular players at the intersection of obesity and osteoarthritis. Curr Drug Targets. 2011, 12: 2103-2128. 10.2174/138945011798829393.CrossRefPubMed Bonet ML, Granados N, Palou A: Molecular players at the intersection of obesity and osteoarthritis. Curr Drug Targets. 2011, 12: 2103-2128. 10.2174/138945011798829393.CrossRefPubMed
22.
go back to reference Prieur X, Mok CY, Velagapudi VR, Núñez V, Fuentes L, Montaner D, Ishikawa K, Camacho A, Barbarroja N, O'Rahilly S, Sethi JK, Dopazo J, Orešič M, Ricote M, Vidal-Puig A: Differential lipid partitioning between adipocytes and tissue macrophages modulates macrophage lipotoxicity and M2/M1 polarization in obese mice. Diabetes. 2011, 60: 797-809. 10.2337/db10-0705.PubMedCentralCrossRefPubMed Prieur X, Mok CY, Velagapudi VR, Núñez V, Fuentes L, Montaner D, Ishikawa K, Camacho A, Barbarroja N, O'Rahilly S, Sethi JK, Dopazo J, Orešič M, Ricote M, Vidal-Puig A: Differential lipid partitioning between adipocytes and tissue macrophages modulates macrophage lipotoxicity and M2/M1 polarization in obese mice. Diabetes. 2011, 60: 797-809. 10.2337/db10-0705.PubMedCentralCrossRefPubMed
23.
go back to reference Tintut Y, Morony S, Demer LL: Hyperlipidemia promotes osteoclastic potential of bone marrow cells ex vivo. Arterioscler Thromb Vasc Biol. 2004, 24: e6-10.CrossRefPubMed Tintut Y, Morony S, Demer LL: Hyperlipidemia promotes osteoclastic potential of bone marrow cells ex vivo. Arterioscler Thromb Vasc Biol. 2004, 24: e6-10.CrossRefPubMed
24.
go back to reference Pelton K, Krieder J, Joiner D, Freeman MR, Goldstein SA, Solomon KR: Hypercholesterolemia promotes an osteoporotic phenotype. Am J Pathol. 2012, 181: 1-9.CrossRef Pelton K, Krieder J, Joiner D, Freeman MR, Goldstein SA, Solomon KR: Hypercholesterolemia promotes an osteoporotic phenotype. Am J Pathol. 2012, 181: 1-9.CrossRef
25.
go back to reference Alvarez-Soria M, Largo R, Santillana J, Sánchez-Pernaute O, Calvo E, Hernández M, Egido J, Herrero-Beaumont G: Long term NSAID treatment inhibits COX-2 synthesis in the knee synovial membrane of patients with osteoarthritis: differential proinflammatory cytokine profile between celecoxib and aceclofenac. Ann Rheum Dis. 2006, 65: 998-1005. 10.1136/ard.2005.046920.PubMedCentralCrossRefPubMed Alvarez-Soria M, Largo R, Santillana J, Sánchez-Pernaute O, Calvo E, Hernández M, Egido J, Herrero-Beaumont G: Long term NSAID treatment inhibits COX-2 synthesis in the knee synovial membrane of patients with osteoarthritis: differential proinflammatory cytokine profile between celecoxib and aceclofenac. Ann Rheum Dis. 2006, 65: 998-1005. 10.1136/ard.2005.046920.PubMedCentralCrossRefPubMed
26.
go back to reference Krenn V, Morawietz L, Häupl T, Neidel J, Petersen I, König A: Grading of chronic synovitis - a histopathological grading system for molecular and diagnostic pathology. Pathol Res Pract. 2002, 198: 317-325. 10.1078/0344-0338-5710261.CrossRefPubMed Krenn V, Morawietz L, Häupl T, Neidel J, Petersen I, König A: Grading of chronic synovitis - a histopathological grading system for molecular and diagnostic pathology. Pathol Res Pract. 2002, 198: 317-325. 10.1078/0344-0338-5710261.CrossRefPubMed
27.
go back to reference Herrero-Beaumont G, Marcos ME, Sánchez-Pernaute O, Granados R, Ortega L, Montell E, Vergés J, Egido J, Largo R: Effect of chondroitin sulphate in a rabbit model of atherosclerosis aggravated by chronic arthritis. Br J Pharmacol. 2008, 154: 843-851.PubMedCentralCrossRefPubMed Herrero-Beaumont G, Marcos ME, Sánchez-Pernaute O, Granados R, Ortega L, Montell E, Vergés J, Egido J, Largo R: Effect of chondroitin sulphate in a rabbit model of atherosclerosis aggravated by chronic arthritis. Br J Pharmacol. 2008, 154: 843-851.PubMedCentralCrossRefPubMed
28.
go back to reference Bellido M, Lugo L, Roman-Blas JA, Castañeda S, Caeiro JR, Dapia S, Calvo E, Largo R, Herrero-Beaumont G: Subchondral bone microstructural damage by increased remodelling aggravates experimental osteoarthritis preceded by osteoporosis. Arthritis Res Ther. 2010, 12: R152-10.1186/ar3103.PubMedCentralCrossRefPubMed Bellido M, Lugo L, Roman-Blas JA, Castañeda S, Caeiro JR, Dapia S, Calvo E, Largo R, Herrero-Beaumont G: Subchondral bone microstructural damage by increased remodelling aggravates experimental osteoarthritis preceded by osteoporosis. Arthritis Res Ther. 2010, 12: R152-10.1186/ar3103.PubMedCentralCrossRefPubMed
30.
go back to reference Martínez-Calatrava MJ, Prieto-Potín I, Roman-Blas JA, Tardio L, Largo R, Herrero-Beaumont G: RANKL synthesized by articular chondrocytes contributes to juxta-articular bone loss in chronic arthritis. Arthritis Res Ther. 2012, 14: R149-10.1186/ar3884.PubMedCentralCrossRefPubMed Martínez-Calatrava MJ, Prieto-Potín I, Roman-Blas JA, Tardio L, Largo R, Herrero-Beaumont G: RANKL synthesized by articular chondrocytes contributes to juxta-articular bone loss in chronic arthritis. Arthritis Res Ther. 2012, 14: R149-10.1186/ar3884.PubMedCentralCrossRefPubMed
31.
go back to reference Rose S, Eren M, Murphy S, Zhang H, Thaxton CS, Chowaniec J, Waters EA, Meade TJ, Vaughan DE, Perlman H: A novel mouse model that develops spontaneous arthritis and is predisposed towards atherosclerosis. Ann Rheum Dis. 2012, 72: 89-95.PubMedCentralCrossRefPubMed Rose S, Eren M, Murphy S, Zhang H, Thaxton CS, Chowaniec J, Waters EA, Meade TJ, Vaughan DE, Perlman H: A novel mouse model that develops spontaneous arthritis and is predisposed towards atherosclerosis. Ann Rheum Dis. 2012, 72: 89-95.PubMedCentralCrossRefPubMed
32.
go back to reference van Halm VP, Nielen MM, Nurmohamed MT, van Schaardenburg D, Reesink HW, Voskuyl AE, Twisk JW, van de Stadt RJ, de Koning MH, Habibuw MR, van der Horst-Bruinsma IE, Dijkmans BA: Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis. Ann Rheum Dis. 2007, 66: 184-188.PubMedCentralCrossRefPubMed van Halm VP, Nielen MM, Nurmohamed MT, van Schaardenburg D, Reesink HW, Voskuyl AE, Twisk JW, van de Stadt RJ, de Koning MH, Habibuw MR, van der Horst-Bruinsma IE, Dijkmans BA: Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis. Ann Rheum Dis. 2007, 66: 184-188.PubMedCentralCrossRefPubMed
33.
go back to reference Karvounaris SA, Sidiropoulos PI, Papadakis JA, Spanakis EK, Bertsias GK, Kritikos HD, Ganotakis ES, Boumpas DT: Metabolic syndrome is common among middle-to-older aged Mediterranean patients with rheumatoid arthritis and correlates with disease activity: a retrospective, cross-sectional, controlled, study. Ann Rheum Dis. 2007, 66: 28-33.PubMedCentralCrossRefPubMed Karvounaris SA, Sidiropoulos PI, Papadakis JA, Spanakis EK, Bertsias GK, Kritikos HD, Ganotakis ES, Boumpas DT: Metabolic syndrome is common among middle-to-older aged Mediterranean patients with rheumatoid arthritis and correlates with disease activity: a retrospective, cross-sectional, controlled, study. Ann Rheum Dis. 2007, 66: 28-33.PubMedCentralCrossRefPubMed
34.
go back to reference Crowson CS, Matteson EL, Davis JM, Gabriel SE: Contribution of obesity to the rise in incidence of rheumatoid arthritis. Arthritis Res Ther. 2013, 65: 71-77.CrossRef Crowson CS, Matteson EL, Davis JM, Gabriel SE: Contribution of obesity to the rise in incidence of rheumatoid arthritis. Arthritis Res Ther. 2013, 65: 71-77.CrossRef
35.
go back to reference Ajeganova S, Andersson ML, Hafström I: Association of obesity with worse disease severity in rheumatoid arthritis as well as with comorbidities: a long-term followup from disease onset. Arthritis Care Res. 2013, 65: 78-87. 10.1002/acr.21710.CrossRef Ajeganova S, Andersson ML, Hafström I: Association of obesity with worse disease severity in rheumatoid arthritis as well as with comorbidities: a long-term followup from disease onset. Arthritis Care Res. 2013, 65: 78-87. 10.1002/acr.21710.CrossRef
36.
go back to reference Klaasen R, Wijbrandts C, Gerlag DM, Tak PP: Body mass index and clinical response to infliximab in rheumatoid arthritis. Arthritis Rheum. 2011, 63: 359-364. 10.1002/art.30136.CrossRefPubMed Klaasen R, Wijbrandts C, Gerlag DM, Tak PP: Body mass index and clinical response to infliximab in rheumatoid arthritis. Arthritis Rheum. 2011, 63: 359-364. 10.1002/art.30136.CrossRefPubMed
37.
go back to reference Gremese E, Carletto A, Padovan M, Atzeni F, Raffeiner B, Giardina AR, Favalli EG, Erre GL, Gorla R, Galeazzi M, Foti R, Cantini F, Salvarani C, Olivieri I, Lapadula G, Ferraccioli G, Gruppo Italiano di Studio sulle Early Arthritis (GISEA): Obesity and reduction of the response rate to anti-tumor necrosis factor α in rheumatoid arthritis: an approach to a personalized medicine. Arthritis Care Res (Hoboken). 2013, 65: 94-100. 10.1002/acr.21768.CrossRef Gremese E, Carletto A, Padovan M, Atzeni F, Raffeiner B, Giardina AR, Favalli EG, Erre GL, Gorla R, Galeazzi M, Foti R, Cantini F, Salvarani C, Olivieri I, Lapadula G, Ferraccioli G, Gruppo Italiano di Studio sulle Early Arthritis (GISEA): Obesity and reduction of the response rate to anti-tumor necrosis factor α in rheumatoid arthritis: an approach to a personalized medicine. Arthritis Care Res (Hoboken). 2013, 65: 94-100. 10.1002/acr.21768.CrossRef
38.
go back to reference Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, Simes R, Cholesterol Treatment Trialists' (CTT) Collaborators: Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005, 366: 1267-1278.CrossRefPubMed Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, Simes R, Cholesterol Treatment Trialists' (CTT) Collaborators: Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005, 366: 1267-1278.CrossRefPubMed
39.
go back to reference McCarey DW, McInnes IB, Madhok R, Hampson R, Scherbakova O, Ford I, Capell HA, Sattar N: Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial. Lancet. 2004, 363: 2015-2021. 10.1016/S0140-6736(04)16449-0.CrossRefPubMed McCarey DW, McInnes IB, Madhok R, Hampson R, Scherbakova O, Ford I, Capell HA, Sattar N: Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial. Lancet. 2004, 363: 2015-2021. 10.1016/S0140-6736(04)16449-0.CrossRefPubMed
40.
go back to reference Paraskevas KI: Statin treatment for rheumatoid arthritis: a promising novel indication. Clin Rheumatol. 2008, 27: 281-287. 10.1007/s10067-007-0806-8.CrossRefPubMed Paraskevas KI: Statin treatment for rheumatoid arthritis: a promising novel indication. Clin Rheumatol. 2008, 27: 281-287. 10.1007/s10067-007-0806-8.CrossRefPubMed
41.
go back to reference Lopez-Pedrera C, Ruiz-Limon P, Valverde-Estepa A, Barbarroja N, Rodriguez-Ariza A: To cardiovascular disease and beyond: new therapeutic perspectives of statins in autoimmune diseases and cancer. Curr Drug Targets. 2012, 13: 829-841. 10.2174/138945012800564112.CrossRefPubMed Lopez-Pedrera C, Ruiz-Limon P, Valverde-Estepa A, Barbarroja N, Rodriguez-Ariza A: To cardiovascular disease and beyond: new therapeutic perspectives of statins in autoimmune diseases and cancer. Curr Drug Targets. 2012, 13: 829-841. 10.2174/138945012800564112.CrossRefPubMed
42.
go back to reference Chodick G, Amital H, Shalem Y, Kokia E, Heymann AD, Porath A, Shalev V: Persistence with statins and onset of rheumatoid arthritis: a population-based cohort study. PLoS Med. 2010, 7: e1000336-10.1371/journal.pmed.1000336.PubMedCentralCrossRefPubMed Chodick G, Amital H, Shalem Y, Kokia E, Heymann AD, Porath A, Shalev V: Persistence with statins and onset of rheumatoid arthritis: a population-based cohort study. PLoS Med. 2010, 7: e1000336-10.1371/journal.pmed.1000336.PubMedCentralCrossRefPubMed
43.
go back to reference Jick SS, Choi H, Li L, McInnes IB, Sattar N: Hyperlipidemia, statin use and the risk of developing rheumatoid arthritis. Ann Rheum Dis. 2009, 68: 546-551. 10.1136/ard.2008.091967.CrossRefPubMed Jick SS, Choi H, Li L, McInnes IB, Sattar N: Hyperlipidemia, statin use and the risk of developing rheumatoid arthritis. Ann Rheum Dis. 2009, 68: 546-551. 10.1136/ard.2008.091967.CrossRefPubMed
44.
go back to reference Kraan MC, Versendaal H, Jonker M, Bresnihan B, Post WJ, t Hart BA, Breedveld FC, Tak PP: Asymptomatic synovitis precedes clinically manifest arthritis. Arthritis Rheum. 1998, 41: 1481-1488. 10.1002/1529-0131(199808)41:8<1481::AID-ART19>3.0.CO;2-O.CrossRefPubMed Kraan MC, Versendaal H, Jonker M, Bresnihan B, Post WJ, t Hart BA, Breedveld FC, Tak PP: Asymptomatic synovitis precedes clinically manifest arthritis. Arthritis Rheum. 1998, 41: 1481-1488. 10.1002/1529-0131(199808)41:8<1481::AID-ART19>3.0.CO;2-O.CrossRefPubMed
45.
go back to reference Haringman JJ, Gerlag DM, Zwinderman AH, Smeets TJ, Kraan MC, Baeten D, McInnes IB, Bresnihan B, Tak PP: Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis. Ann Rheum Dis. 2005, 64: 834-838. 10.1136/ard.2004.029751.PubMedCentralCrossRefPubMed Haringman JJ, Gerlag DM, Zwinderman AH, Smeets TJ, Kraan MC, Baeten D, McInnes IB, Bresnihan B, Tak PP: Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis. Ann Rheum Dis. 2005, 64: 834-838. 10.1136/ard.2004.029751.PubMedCentralCrossRefPubMed
46.
go back to reference Murano I, Barbatelli G, Parisani V, Latini C, Muzzonigro G, Castellucci M: Dead adipocytes, detected as crown-like structures, are prevalent in visceral fat depots of genetically obese mice. J Lipid Res. 2008, 49: 1562-1568. 10.1194/jlr.M800019-JLR200.CrossRefPubMed Murano I, Barbatelli G, Parisani V, Latini C, Muzzonigro G, Castellucci M: Dead adipocytes, detected as crown-like structures, are prevalent in visceral fat depots of genetically obese mice. J Lipid Res. 2008, 49: 1562-1568. 10.1194/jlr.M800019-JLR200.CrossRefPubMed
47.
go back to reference Dushkin MI: Macrophage/foam cell is an attribute of inflammation: mechanisms of formation and functional role. Biochemistry (Mosc). 2012, 77: 327-38. 10.1134/S0006297912040025.CrossRef Dushkin MI: Macrophage/foam cell is an attribute of inflammation: mechanisms of formation and functional role. Biochemistry (Mosc). 2012, 77: 327-38. 10.1134/S0006297912040025.CrossRef
48.
49.
go back to reference Lumeng CN, Deyoung SM, Bodzin JL, Saltiel AR: Increased inflammatory properties of adipose tissue macrophages recruited during diet-induced obesity. Diabetes. 2007, 56: 16-23. 10.2337/db06-1076.CrossRefPubMed Lumeng CN, Deyoung SM, Bodzin JL, Saltiel AR: Increased inflammatory properties of adipose tissue macrophages recruited during diet-induced obesity. Diabetes. 2007, 56: 16-23. 10.2337/db06-1076.CrossRefPubMed
50.
go back to reference Kume K, Satomura K, Nishisho S, Kitaoka E, Yamanouchi K, Tobiume S, Nagayama M: Potential role of leptin in endochondral ossification. J Histochem Cytochem. 2002, 50: 159-169. 10.1177/002215540205000204.CrossRefPubMed Kume K, Satomura K, Nishisho S, Kitaoka E, Yamanouchi K, Tobiume S, Nagayama M: Potential role of leptin in endochondral ossification. J Histochem Cytochem. 2002, 50: 159-169. 10.1177/002215540205000204.CrossRefPubMed
51.
go back to reference Chase J: Role of nuclear factor-kappaB activation in metalloproteinase-1, -3, and -9 secretion by human macrophages in vitro and rabbit foam cells produced in vivo. Arterioscler Thromb Vasc Biol. 2002, 22: 765-771. 10.1161/01.ATV.0000015078.09208.92.CrossRefPubMed Chase J: Role of nuclear factor-kappaB activation in metalloproteinase-1, -3, and -9 secretion by human macrophages in vitro and rabbit foam cells produced in vivo. Arterioscler Thromb Vasc Biol. 2002, 22: 765-771. 10.1161/01.ATV.0000015078.09208.92.CrossRefPubMed
53.
go back to reference Barascuk N, Skjøt-Arkil H, Register TC, Larsen L, Byrjalsen I, Christiansen C, Karsdal MA: Human macrophage foam cells degrade atherosclerotic plaques through cathepsin K mediated processes. BMC Cardiovasc Disord. 2010, 10: 19-10.1186/1471-2261-10-19.PubMedCentralCrossRefPubMed Barascuk N, Skjøt-Arkil H, Register TC, Larsen L, Byrjalsen I, Christiansen C, Karsdal MA: Human macrophage foam cells degrade atherosclerotic plaques through cathepsin K mediated processes. BMC Cardiovasc Disord. 2010, 10: 19-10.1186/1471-2261-10-19.PubMedCentralCrossRefPubMed
54.
go back to reference Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW: Obesity is associated with macrophage accumulation. J Clin Invest. 2003, 112: 1796-1808.PubMedCentralCrossRefPubMed Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW: Obesity is associated with macrophage accumulation. J Clin Invest. 2003, 112: 1796-1808.PubMedCentralCrossRefPubMed
55.
go back to reference Okayasu M, Nakayachi M, Hayashida C, Ito J, Kaneda T, Masuhara M, Suda N, Sato T, Hakeda Y: Low-density lipoprotein receptor deficiency causes impaired osteoclastogenesis and increased bone mass in mice because of defect in osteoclastic cell-cell fusion. J Biol Chem. 2012, 287: 19229-19241. 10.1074/jbc.M111.323600.PubMedCentralCrossRefPubMed Okayasu M, Nakayachi M, Hayashida C, Ito J, Kaneda T, Masuhara M, Suda N, Sato T, Hakeda Y: Low-density lipoprotein receptor deficiency causes impaired osteoclastogenesis and increased bone mass in mice because of defect in osteoclastic cell-cell fusion. J Biol Chem. 2012, 287: 19229-19241. 10.1074/jbc.M111.323600.PubMedCentralCrossRefPubMed
56.
go back to reference Maeda K, Takahashi N, Kobayashi Y: Roles of Wnt signals in bone resorption during physiological and pathological states. J Mol Med (Berl). 2013, 91: 15-23. 10.1007/s00109-012-0974-0.CrossRef Maeda K, Takahashi N, Kobayashi Y: Roles of Wnt signals in bone resorption during physiological and pathological states. J Mol Med (Berl). 2013, 91: 15-23. 10.1007/s00109-012-0974-0.CrossRef
Metadata
Title
Hypercholesterolemia boosts joint destruction in chronic arthritis. An experimental model aggravated by foam macrophage infiltration
Authors
I Prieto-Potín
JA Roman-Blas
MJ Martínez-Calatrava
R Gómez
R Largo
Gabriel Herrero-Beaumont
Publication date
01-08-2013
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 4/2013
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar4261

Other articles of this Issue 4/2013

Arthritis Research & Therapy 4/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine